The resurgence of platinum-based cancer chemotherapy
- PMID: 17625587
- DOI: 10.1038/nrc2167
The resurgence of platinum-based cancer chemotherapy
Abstract
The accidental discovery of the anticancer properties of cisplatin and its clinical introduction in the 1970s represent a major landmark in the history of successful anticancer drugs. Although carboplatin--a second-generation analogue that is safer but shows a similar spectrum of activity to cisplatin--was introduced in the 1980s, the pace of further improvements slowed for many years. However, in the past several years interest in platinum drugs has increased. Key developments include the elucidation of mechanisms of tumour resistance to these drugs, the introduction of new platinum-based agents (oxaliplatin, satraplatin and picoplatin), and clinical combination studies using platinum drugs with resistance modulators or new molecularly targeted drugs.
Comment in
-
Peripheral neurotoxicity of platinum-based chemotherapy.Nat Rev Cancer. 2008 Jan;8(1):1p following 71; author reply 1p following 71. doi: 10.1038/nrc2167-c1. Nat Rev Cancer. 2008. PMID: 18159632 No abstract available.
Similar articles
-
Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers.Semin Oncol. 2004 Dec;31(6 Suppl 14):17-24. doi: 10.1053/j.seminoncol.2004.11.007. Semin Oncol. 2004. PMID: 15726530 Review.
-
Current status and future prospects for satraplatin, an oral platinum analogue.Clin Cancer Res. 2008 Mar 15;14(6):1633-8. doi: 10.1158/1078-0432.CCR-07-2176. Clin Cancer Res. 2008. PMID: 18347164 Review.
-
Mechanisms of resistance of human tumours to anticancer drugs of the platinum family: a review.J Otolaryngol. 1995 Aug;24(4):242-52. J Otolaryngol. 1995. PMID: 8551538 Review.
-
New-generation platinum agents for solid tumors.Future Oncol. 2009 Feb;5(1):33-42. doi: 10.2217/14796694.5.1.33. Future Oncol. 2009. PMID: 19243296 Review.
-
Evolution of chemotherapy with platinum compounds.Ann Clin Lab Sci. 1999 Oct-Dec;29(4):263-74. Ann Clin Lab Sci. 1999. PMID: 10528825 Review.
Cited by
-
Evaluation of Cisplatin-Induced Pathology in the Larval Zebrafish Lateral Line.Int J Mol Sci. 2022 Nov 18;23(22):14302. doi: 10.3390/ijms232214302. Int J Mol Sci. 2022. PMID: 36430778 Free PMC article.
-
Histological changes in kidney and liver of rats due to gold (III) compound [Au(en)Cl(2)]Cl.PLoS One. 2012;7(12):e51889. doi: 10.1371/journal.pone.0051889. Epub 2012 Dec 27. PLoS One. 2012. PMID: 23300573 Free PMC article.
-
Catalytic nanomedicine technology: copper complexes loaded on titania nanomaterials as cytotoxic agents of cancer cell.Int J Nanomedicine. 2013;8:581-92. doi: 10.2147/IJN.S37118. Epub 2013 Feb 9. Int J Nanomedicine. 2013. PMID: 23413123 Free PMC article.
-
Role of Epigenetics for the Efficacy of Cisplatin.Int J Mol Sci. 2024 Jan 17;25(2):1130. doi: 10.3390/ijms25021130. Int J Mol Sci. 2024. PMID: 38256203 Free PMC article. Review.
-
A monomer purified from Paris polyphylla (PP-22) triggers S and G2/M phase arrest and apoptosis in human tongue squamous cell carcinoma SCC-15 by activating the p38/cdc25/cdc2 and caspase 8/caspase 3 pathways.Tumour Biol. 2016 Nov;37(11):14863-14872. doi: 10.1007/s13277-016-5376-4. Epub 2016 Sep 19. Tumour Biol. 2016. PMID: 27644244
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
